Biobank in Genomics

The stated aim of the Genomics and Personalized Medicine Act is to secure the promise of personalized medicine for all Americans by expanding and accelerating genomics research and initiatives to improve the accuracy of disease diagnosis, increase the safety of drugs, and identify novel treatments, and for other purposes. This past May, Congressman Patrick Kennedy (D-RI) and Congresswoman Anna Eshoo (D-CA) re-introduced a personalized medicine bill to the U.S. House of Representatives. The bill was originally introduced in 2006 by then-Senator from Illinois Barack Obama. While HR 5440, also known as the Genomics and Personalized Medicine Act of 2010 (GPMA 2010) Despite its narrow definition of personalized medicine, GPMA 2010 includes several expansive initiatives. GPMA 2010 would appropriate $150 million for fiscal year 2011 to accomplish these initiatives, including the creation of an Office of Personalized Healthcare and several committees to address translational challenges of personalized medicine, the standardization of the collection of human biological samples, the funding of further research and education on personalized medicine, and the creation of a national Biobanks.

Genomic Sample Prep and Biomarker Assay Development San Francisco, USA, Managing Biomarker-Driven Clinical Trials Miami, USA, The Biomarker Conference Orlando, Florida, USA, ART World Congress Symposium on Safe and Efficient IVF New York City, USA, World Conference on Regenerative Medicine 2015 Leipzig, Germany, Craniofacial Morphogenesis & Tissue Regeneration Ventura, CA, USA, Keystone Stem Cells and Cancer Breckenbridge, CO, USA, Keystone Stem Cells and Regeneration in the Digestive Organs (X6) Keystone, Colorado, USA, Stem Cells: from Basic Biology to Therapeutic Application Suzhou, China, EMBL Hematopoietic Stem Cells: From the Embryo to the Aging Organism Heidelberg, Germany.

In 2008 United States researchers stored 270 million specimens in biobanks, and the rate of new sample collection was 20 million per year. These numbers are large and representative of a fundamental worldwide change in the nature of research between the time when such numbers of samples could not be used and the time when researchers began demanding them.Collectively, researchers began to progress beyond single-center research centers to a next-generation qualitatively different research infrastructure. Some of the challenges raised by the advent of biobanks are ethical, legal, and social issues pertaining to their existence, including the fairness of collecting donations from vulnerable populations, providing informed consent to donors, the logistics of data disclosure to participants, the right to ownership of intellectual property, and the privacy and security of donors who participate. Because of these new problems, researchers and policymakers began to require new systems of research governance.

Genetic studies based on biobanking are becoming increasingly common as researchers recognize the need for large amounts of samples to identify the genetic basis of susceptibility to common complex diseases. Large scale population biobanking projects link genetic data with information on health status, lifestyle and environmental factors.

  • The appliactions of Banked Samples for Whole Genome/Exome Sequencing Studies 
  • Added Value Of Biobanks For Health: An Evolutionary Perspective
  • Challenges in Sampling and Storage of DNA: A Pharmacogenetics Perspective
  • How Biobank is needed for drug discovery and development?
  • Human Genome Project

Related Conference of Biobank in Genomics

July 23-24, 2018

Annual Biotechnology Congress

Vancouver, British Columbia, Canada
September 3-4, 2018

World Congress on Stem Cell Biology and Biobanking

Tokyo, Japan
September 10-11, 2018

22nd Global Biotechnology Congress

Stockholm, Sweden
September 19 - 20, 2018

2nd Annual summit on Cell Signaling and Cancer Therapy

Philadelphia, Pennsylvania, USA
September 19 - 20, 2018

2nd Annual summit on Cell Metabolism and Cytopathology

Philadelphia, Pennsylvania, USA
September 21-22, 2018

11th International Conference on Genomics and Pharmacogenomics

Philadelphia, Pennsylvania, USA
September 21-22, 2018

5th International Conference on Human Genetics and Genetic Diseases

Philadelphia, Pennsylvania, USA
November 27-28, 2018

8th International Conference on Cell & Gene Therapy

Athens, Greece
October 08-09, 2018

10th Annual Conference on Stem Cell and Regenerative Medicine

Zurich, Switzerland
October 11-12, 2018

21st European Biotechnology Congress

Holiday Inn Vinogradovo, Moscow, Russia
October 24-25, 2018

24th Biotechnology Congress: Research & Innovations

Crowne Plaza Newton Hotel, Boston, Massachusetts, USA
November 9-10, 2018

2nd Annual Summit on Stem Cell Research, Cell and Gene Therapy

Atlanta, Georgia, USA
November 15-16, 2018

5th World Congress on Epigenetics and Chromosome

Istanbul, Turkey
November 19-20, 2018

22nd World Congress on Biotechnology

Bangkok, Thailand
November 26-27, 2018

International Epigenetics and Epitranscriptomics Conference

Helsinki,Finland
Dec 03-04, 2018

3rd World Biotechnology Congress


(10 Plenary Forums - 1Event)
Sao Paulo, Brazil
March 11-12, 2019

12th World Congress on Cell & Tissue Science

Singapore
March 20-21, 2019

2nd World Congress on Cell and Structural Biology

Sydney, Australia
March 25-26, 2019

11th World Congress and Expo on Cell & Stem Cell Research

Orlando, Florida, USA
March 27-28, 2019

World Congress on Molecular Biology & Genetics


Orlando |Florida| USA
April 15-16, 2019

7th International Conference on Integrative Biology

Berlin, Germany
April 22-23, 2019

International Conference on Cord Blood Banking

Vancouver, British Columbia, Canada
June 10-12, 2019

10 th Tissue Repair and Regeneration Congress

Helsinki, Finland

Biobank in Genomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in